Found 8 matching trials
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) PHASE3 This Phase III, randomized, open-label, multicenter study will evaluate the...
Show More Status
Active Not Recruiting
Location
Alaska Oncology & Hematology, LLC
Learn More & Join Trial
Everolimus Aging Study PHASE2 The objective of this project is to determine if mTORC1 inhibition by 24 we...
Show More Location
University of Wisconsin-Madison
Learn More & Join Trial
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors PHASE1 This trial was a Phase I/II, non-randomized, open label, multi-center study...
Show More Location
Dana Farber Cancer Institute Dept of Sarcoma Oncology
Learn More & Join Trial
Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry PHASE3 The CLEAR SYNERGY trial will study the long term effects of treatments foll...
Show More Location
Central Cardiology
Learn More & Join Trial
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. PHASE3 This trial will study a type of advanced breast cancer (ABC) defined as end...
Show More Location
Medizinische Universität Innsbruck
Learn More & Join Trial
Regimen Optimization Study PHASE2 Patients who undergo a kidney transplant require prolonged therapy with dru...
Show More Location
California Institute Of Renal Research
Learn More & Join Trial
Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients PHASE4 The investigators hypothesize that switching kidney transplant patients on ...
Show More Location
Multiple Locations
Learn More & Join Trial
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration PHASE2 The study will assess the safety and efficacy of Everolimus (RAD001) alone ...
Show More Location
Retina-Vitreous Associates Medical Group
Learn More & Join Trial